By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare has invested $5 million in molecular diagnostics firm CardioDx as part of a Series D round of financing for the startup.

GE Healthcare also said that it has formed an alliance with the Palo Alto, Calif.-based firm to co-develop diagnostic technologies for the care and management of patients with cardiovascular disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Patients who've learned their genetic risk of disease worry about healthcare law changes in the US, Kaiser Health News reports.

Hopkins' Geoffrey Ling discusses the promise of genomic vaccines at Scientific American.

In Nature this week: mitochondrial genome of extinct South American ungulate, and more.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.